Concanavalin a affinity chromatography for efficient baculovirus purification
暂无分享,去创建一个
[1] K. Airenne,et al. Targeting and purification of metabolically biotinylated baculovirus. , 2008, Human gene therapy.
[2] K. Airenne,et al. Generation of lentivirus vectors using recombinant baculoviruses , 2008, Gene Therapy.
[3] Li-Yu Sung,et al. Combination of baculovirus-expressed BMP-2 and rotating-shaft bioreactor culture synergistically enhances cartilage formation , 2008, Gene Therapy.
[4] Yu-Chen Hu. Baculoviral vectors for gene delivery: a review. , 2008, Current gene therapy.
[5] Y. Matsuura,et al. Baculovirus vector for gene delivery and vaccine development , 2008 .
[6] Y. Lai,et al. Combination of baculovirus-mediated gene delivery and packed-bed reactor for scalable production of adeno-associated virus. , 2007, Human gene therapy.
[7] Y. Durocher,et al. Production of lentiviral vectors by large‐scale transient transfection of suspension cultures and affinity chromatography purification , 2007, Biotechnology and bioengineering.
[8] Li-Yu Sung,et al. Baculovirus as a new gene delivery vector for stem cell engineering and bone tissue engineering , 2007, Gene Therapy.
[9] Chunxiao Wu,et al. Ion-exchange membrane chromatography method for rapid and efficient purification of recombinant baculovirus and baculovirus gp64 protein. , 2007, Human gene therapy.
[10] A. Kamen,et al. High yield purification of functional baculovirus vectors by size exclusion chromatography. , 2007, Journal of virological methods.
[11] Thomas A Kost,et al. Implementation of BacMam virus gene delivery technology in a drug discovery setting. , 2007, Drug discovery today.
[12] Y. Lai,et al. Avian influenza virus hemagglutinin display on baculovirus envelope: cytoplasmic domain affects virus properties and vaccine potential. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.
[13] D. Schaffer,et al. Engineering adeno-associated virus for one-step purification via immobilized metal affinity chromatography. , 2007, Human gene therapy.
[14] K. Airenne,et al. SPECT/CT imaging of baculovirus biodistribution in rat , 2007, Gene Therapy.
[15] Yu-Chen Hu,et al. Factors influencing the production and storage of baculovirus for gene delivery: An alternative perspective from the transducing titer assay , 2007 .
[16] P. Cruz,et al. Scaleable purification process for gene therapy retroviral vectors , 2007, The journal of gene medicine.
[17] N. Palanisamy,et al. Baculoviral Vector‐Mediated Transient and Stable Transgene Expression in Human Embryonic Stem Cells , 2007, Stem cells.
[18] U. Reichl,et al. Purification of cell culture‐derived human influenza A virus by size‐exclusion and anion‐exchange chromatography , 2006, Biotechnology and bioengineering.
[19] A. Kamen,et al. Primary recovery and chromatographic purification of adeno-associated virus type 2 produced by baculovirus/insect cell system. , 2007, Journal of virological methods.
[20] S. Tuve,et al. Baculovirus-based vaccination vectors allow for efficient induction of immune responses against plasmodium falciparum circumsporozoite protein. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.
[21] P. Czermak,et al. Purification of Densonucleosis Virus by Tangential Flow Ultrafiltration , 2008, Biotechnology progress (Print).
[22] M. V. van Oers. Vaccines for Viral and Parasitic Diseases Produced with Baculovirus Vectors , 2006, Advances in Virus Research.
[23] C. Oker-Blom,et al. Baculovirus Display: A Multifunctional Technology for Gene Delivery and Eukaryotic Library Development , 2006, Advances in Virus Research.
[24] J. Bartlett,et al. Metabolic biotinylation provides a unique platform for the purification and targeting of multiple AAV vector serotypes. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.
[25] Yi-Chen Ho,et al. Baculovirus transduction of human mesenchymal stem cell-derived progenitor cells: variation of transgene expression with cellular differentiation states , 2006, Gene Therapy.
[26] P. Alves,et al. Effect of osmotic pressure on the production of retroviral vectors: Enhancement in vector stability , 2006, Biotechnology and bioengineering.
[27] A. Kamen,et al. Analysis of baculovirus aggregates using flow cytometry. , 2006, Journal of virological methods.
[28] Shu Wang,et al. Recombinant baculovirus containing the diphtheria toxin A gene for malignant glioma therapy. , 2006, Cancer research.
[29] Yu-Chen Hu,et al. Determination of the baculovirus transducing titer in mammalian cells , 2006, Biotechnology and bioengineering.
[30] Arvind H. Patel,et al. Characterization of HCV-like particles produced in a human hepatoma cell line by a recombinant baculovirus. , 2006, Biochemical and biophysical research communications.
[31] K. Airenne,et al. Truncated vesicular stomatitis virus G protein improves baculovirus transduction efficiency in vitro and in vivo , 2006, Gene Therapy.
[32] M. M. Oers,et al. Vaccines for viral and parasitic diseases produced with baculovirus vectors. , 2006 .
[33] R. Ames,et al. Baculoviruses and mammalian cell-based assays for drug screening. , 2006, Advances in virus research.
[34] U. Reichl,et al. Tangential flow microfiltration and ultrafiltration for human influenza A virus concentration and purification. , 2005, Biotechnology and bioengineering.
[35] V. Baekelandt,et al. Upscaling of lentiviral vector production by tangential flow filtration , 2005, The journal of gene medicine.
[36] A. Kamen,et al. A novel purification strategy for retrovirus gene therapy vectors using heparin affinity chromatography. , 2005, Biotechnology and bioengineering.
[37] Thomas A Kost,et al. Baculovirus as versatile vectors for protein expression in insect and mammalian cells , 2005, Nature Biotechnology.
[38] J. Carlsson,et al. Preparation of high-density Concanavalin A adsorbent and its use for rapid, high-yield purification of peroxidase from horseradish roots. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[39] G. Nemerow,et al. Membrane Cofactor Protein Is a Receptor for Adenoviruses Associated with Epidemic Keratoconjunctivitis , 2004, Journal of Virology.
[40] Masayoshi Onishi,et al. In Vitro and In Vivo Gene Delivery by Recombinant Baculoviruses , 2003, Journal of Virology.
[41] J. Hsu,et al. Generation of chimeric baculovirus with histidine-tags displayed on the envelope and its purification using immobilized metal affinity chromatography , 2003 .
[42] A. Cámara-Artigas,et al. Purification of angiotensin I converting enzyme from pig lung using concanavalin-A sepharose chromatography. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[43] Marcel Kuiper,et al. Purification of a functional gene therapy vector derived from Moloney murine leukaemia virus using membrane filtration and ceramic hydroxyapatite chromatography , 2002, Biotechnology and bioengineering.
[44] M. O. Scott,et al. A new scalable method for the purification of recombinant adenovirus vectors. , 2002, Human gene therapy.
[45] A. Kamen,et al. Quantitation of baculovirus particles by flow cytometry. , 2002, Journal of virological methods.
[46] M. Ataai,et al. Evaluation of Infection Parameters in the Production of Replication‐Defective HSV‐1 Viral Vectors , 2002, Biotechnology progress.
[47] L. Volkman,et al. Filamentous actin is required for lepidopteran nucleopolyhedrovirus progeny production. , 2000, Journal of General Virology.
[48] J. Barsoum. Concentration of recombinant baculovirus by cation-exchange chromatography. , 1999, BioTechniques.
[49] D. O'reilly,et al. Baculovirus expression vectors: a laboratory manual. , 1992 .
[50] P. Ray,et al. Differential binding affinity of immobilized Concanavalin A-Sepharose 4B for normal and myelomatous immunoglobulins. , 1982, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.